Publication: Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
dc.contributor.author | Zafrir, Barak | |
dc.contributor.author | Lund, Lars H | |
dc.contributor.author | Laroche, Cecile | |
dc.contributor.author | Ruschitzka, Frank | |
dc.contributor.author | Crespo-Leiro, Maria G | |
dc.contributor.author | Coats, Andrew J S | |
dc.contributor.author | Anker, Stefan D | |
dc.contributor.author | Filippatos, Gerasimos | |
dc.contributor.author | Seferovic, Petar M | |
dc.contributor.author | Maggioni, Aldo P | |
dc.contributor.author | De-Mora-Martin, Manuel | |
dc.contributor.author | Polonski, Lech | |
dc.contributor.author | Silva-Cardoso, Jose | |
dc.contributor.author | Amir, Offer | |
dc.contributor.group | ESC-HFA HF Long-Term Registry Investigators | |
dc.date.accessioned | 2023-01-25T10:23:23Z | |
dc.date.available | 2023-01-25T10:23:23Z | |
dc.date.issued | 2018-10-15 | |
dc.description.abstract | To investigate the characteristics long-term prognostic implications (up to ∼2.2 years) of atrial fibrillation (AF) compared to sinus rhythm (SR), between acute and chronic heart failure (HF) with reduced (HFrEF Data from the observational, prospective, HF long-term registry of the European Society of Cardiology were analysed. A total of 14 964 HF patients (age 66 ± 13 years, 67% male; 53% HFrEF, 21% HFmrEF, 26% HFpEF) were enrolled. The prevalence of AF was 27% in HFrEF, 29% in HFmrEF, and 39% in HFpEF. Atrial fibrillation was associated with older age, lower functional capacity, and heightened physical signs of HF. Crude rates of mortality and HF hospitalization were higher in patients with AF compared to SR, in each EF subtype. After multivariable adjustment, the hazard ratio of AF for HF hospitalizations was: 1.036 (95% CI 0.888-1.208, P = 0.652) in HFrEF, 1.430 (95% CI 1.087-1.882, P = 0.011) in HFmrEF, and 1.487 (95% CI 1.195-1.851, P The prevalence of AF increases with increasing EF but its association with worse cardiovascular outcomes, remained significant in patients with HFpEF and HFmrEF, but not in those with HFrEF. | |
dc.description.sponsorship | Since the start of EORP, the following companies have supported the program: Abbott Vascular Int. (2011–2014), Amgen Cardiovascular (2009–2018), AstraZeneca (2014–2017), Bayer AG (2009–2018), Boehringer Ingelheim (2009–2019), Boston Scientific (2009–2012), The Bristol Myers Squibb and Pfizer Alliance (2011–2019), Daiichi Sankyo Europe GmbH (2011–2020), The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2014–2017), Edwards (2016–2019), Gedeon Richter Plc. (2014–2016), Menarini Int. Op. (2009–2012), MSD-Merck & Co. (2011–2014), Novartis Pharma AG (2014–2017), ResMed (2014–2016), Sanofi (2009–2011), and SERVIER (2009–2018). | |
dc.description.version | Si | |
dc.identifier.citation | Zafrir B, Lund LH, Laroche C, Ruschitzka F, Crespo-Leiro MG, Coats AJS, et al. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J. 2018 Dec 21;39(48):4277-4284 | |
dc.identifier.doi | 10.1093/eurheartj/ehy626 | |
dc.identifier.essn | 1522-9645 | |
dc.identifier.pmid | 30325423 | |
dc.identifier.unpaywallURL | https://academic.oup.com/eurheartj/article-pdf/39/48/4277/27206071/ehy626.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/13090 | |
dc.issue.number | 48 | |
dc.journal.title | European heart journal | |
dc.journal.titleabbreviation | Eur Heart J | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.page.number | 4277-4284 | |
dc.provenance | Realizada la curación de contenido 19/02/2025 | |
dc.publisher | Oxford University Press | |
dc.pubmedtype | Comparative Study | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Multicenter Study | |
dc.pubmedtype | Observational Study | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.relation.publisherversion | https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehy626 | |
dc.rights.accessRights | Restricted Access | |
dc.subject | Heart failure | |
dc.subject | Atrial fibrillation | |
dc.subject | Hospitalizations | |
dc.subject | Mortality | |
dc.subject | Ejection fraction | |
dc.subject | Prognosis | |
dc.subject.decs | Prevalencia | |
dc.subject.decs | Fibrilación atrial | |
dc.subject.decs | Hospitalización | |
dc.subject.decs | Insuficiencia cardíaca | |
dc.subject.decs | Cardiología | |
dc.subject.decs | Adaptación psicológica | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Atrial Fibrillation | |
dc.subject.mesh | Cardiology | |
dc.subject.mesh | Cause of Death | |
dc.subject.mesh | Europe | |
dc.subject.mesh | Female | |
dc.subject.mesh | Heart Failure | |
dc.subject.mesh | Hospitalization | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Prospective Studies | |
dc.subject.mesh | Societies, Medical | |
dc.subject.mesh | Stroke Volume | |
dc.title | Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 39 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- RISalud_Accesorestringido.pdf
- Size:
- 93.39 KB
- Format:
- Adobe Portable Document Format